Managed care
San Judas Medical Group Ipa
San Judas Medical Group Ipa was paid $343K by Medicaid between Jan 2018 and Dec 2024, across 117 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 13% of everything it billed.
33Billing provider infoSAN JUDAS MEDICAL GROUP IPA
LOS ANGELES, CA 90029
LOS ANGELES, CA 90029
33aNPI1598928814assigned 07/07/2008
33bProvider typeHealth Maintenance Organization
28Total paid$343K
24GClaims172,642
24DCodes billed117
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#47 of 151
Median peer was paid$59K
This provider vs. median5.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 78,147 | $39K | |
| 2019 | 43,495 | $145K | |
| 2020 | 31,673 | $79K | |
| 2021 | 17,820 | $81K | |
| 2024incomplete | 1,507 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 13% | 519 | 392 | $43K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 451 | 439 | $41K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 12% | 124 | 123 | $40K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.5% | 520 | 506 | $32K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.1% | 4,835 | 4,818 | $25K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.2% | 5,458 | 5,447 | $21K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.7% | 3,068 | 3,057 | $19K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.6% | 694 | 691 | $12K |
| 92551 | 3.6% | 10,996 | 10,955 | $12K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.5% | 2,188 | 2,174 | $8K |
| 96150 | 2.0% | 753 | 748 | $7K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.0% | 190 | 180 | $7K |
105 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.9% | 274 | $7K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.4% | 135 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.3% | 1,053 | $5K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 1.3% | 170 | $5K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 166 | $4K |
| V2020 | Frames, purchases | 1.1% | 188 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.1% | 1,082 | $4K |
| 85018 | 1.1% | 14,716 | $4K | |
| 90651 | <1% | 1,843 | $2K | |
| 90670 | <1% | 2,210 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 7,895 | $2K |
| 90633 | <1% | 1,495 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 972 | $2K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 49 | $2K |
| 90698 | <1% | 1,563 | $2K | |
| 90716 | <1% | 1,484 | $2K | |
| 90686 | <1% | 3,472 | $2K | |
| 90707 | <1% | 1,370 | $2K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 15 | $2K |
| 90715 | <1% | 930 | $1K | |
| 90734 | <1% | 1,300 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,125 | $1K |
| 90680 | <1% | 1,306 | $1K | |
| 92015 | Determination of refractive state | <1% | 253 | $1K |
| 90620 | <1% | 836 | $1K | |
| 90744 | <1% | 1,038 | $1K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 30,511 | $1K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 118 | $995.19 |
| 90696 | <1% | 761 | $963.00 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 15 | $925.73 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 13 | $667.03 |
| 90700 | <1% | 694 | $549.00 | |
| 83655 | <1% | 1,168 | $526.19 | |
| 90648 | <1% | 495 | $495.00 | |
| 86580 | <1% | 711 | $436.23 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 3,464 | $417.30 |
| 81025 | <1% | 552 | $393.37 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,019 | $323.95 |
| 99000 | <1% | 7,019 | $243.17 | |
| 81000 | <1% | 7,460 | $194.50 | |
| 86703 | <1% | 689 | $191.24 | |
| 80053 | Comprehensive metabolic panel | <1% | 2,903 | $191.04 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 971 | $153.79 |
| 86592 | <1% | 1,068 | $104.17 | |
| 96156 | <1% | 334 | $100.00 | |
| 90714 | <1% | 229 | $90.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 136 | $65.78 |
| 80061 | Lipid panel | <1% | 3,255 | $55.81 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,104 | $53.71 |
| 84702 | <1% | 30 | $40.27 | |
| 82947 | <1% | 534 | $36.28 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 227 | $29.68 |
| G9920 | Screening performed and negative | <1% | 333 | $29.00 |
| 90672 | <1% | 684 | $27.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,462 | $24.67 |
| 99173 | <1% | 11,106 | $24.29 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 883 | $23.44 |
| A4649 | Surgical supply; miscellaneous | <1% | 64 | $20.55 |
| 81001 | <1% | 130 | $5.33 | |
| 92556 | 0% | 457 | $0.00 | |
| 3079F | 0% | 39 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 1,373 | $0.00 |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | 0% | 1,345 | $0.00 |
| 87110 | 0% | 314 | $0.00 | |
| 87088 | 0% | 64 | $0.00 | |
| 82951 | 0% | 108 | $0.00 | |
| 96127 | 0% | 178 | $0.00 | |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | 0% | 54 | $0.00 |
| 90657 | 0% | 409 | $0.00 | |
| 99384 | 0% | 26 | $0.00 | |
| 3074F | 0% | 73 | $0.00 | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 0% | 474 | $0.00 |
| 87590 | 0% | 149 | $0.00 | |
| 59430 | 0% | 12 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 351 | $0.00 |
| 87070 | 0% | 102 | $0.00 | |
| 82670 | 0% | 12 | $0.00 | |
| 99385 | 0% | 67 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 59 | $0.00 |
| 99381 | 0% | 77 | $0.00 | |
| 99383 | 0% | 81 | $0.00 | |
| 3044F | 0% | 12 | $0.00 | |
| 3080F | 0% | 12 | $0.00 | |
| 80055 | 0% | 13 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 115 | $0.00 |
| 94664 | 0% | 51 | $0.00 | |
| 81002 | 0% | 528 | $0.00 | |
| 59425 | 0% | 1,820 | $0.00 | |
| 3077F | 0% | 112 | $0.00 | |
| 99199 | Unlisted special service, procedure or report | 0% | 44 | $0.00 |
| H0003 | Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs | 0% | 136 | $0.00 |
| 92081 | 0% | 990 | $0.00 | |
| 84439 | 0% | 68 | $0.00 | |
| 99188 | 0% | 1,507 | $0.00 | |
| 90713 | 0% | 82 | $0.00 | |
| 3078F | 0% | 156 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 15 | $0.00 |
| 99382 | 0% | 40 | $0.00 | |
| 84481 | 0% | 61 | $0.00 | |
| 80076 | 0% | 58 | $0.00 | |
| 80306 | 0% | 27 | $0.00 | |
| G8511 | Screening for depression documented as positive, follow-up plan not documented, reason not given | 0% | 12 | $0.00 |
| 92552 | 0% | 55 | $0.00 | |
| 99204 | Doctor's office visit, new patient (more involved) | 0% | 14 | $0.00 |
| 86677 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROSTAMI, NEJAT (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| San Judas Community Health Center, INC. | Los Angeles, CA | $15.75M |
| San Judas Community Health Center, INC | Los Angeles, CA | $15.72M |
| Nejat Rostami Medical Group INC | Los Angeles, CA | $3.31M |
| San Judas Medical Group West | Los Angeles, CA | $2.83M |
| N. Rostami Medical Group, INC. | Los Angeles, CA | $1.32M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.